![Ted Love](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ted Love
Directeur/Membre du Conseil chez
GILEAD SCIENCES, INC.
Fortune : 5 M $ au 31/08/2026
Profil
Ted W.
Love is Independent Director at Gilead Sciences, Inc. since 2024; Director at Biotechnology Innovation Organization starting 2025; Non-Executive Director at Avillion LLP since 2014; Independent Director at Structure Therapeutics, Inc. since 2023; Lead Independent Director at Royalty Pharma Plc starting 2025; Director at Life Science Cares Bay Area; and Independent Director at Jazz Pharmaceuticals Plc starting 2025.
Former roles include Chairman, President & Chief Executive Officer at Nuvelo, Inc. from 2001 to 2009; President, Chief Executive Officer & Director at Global Blood Therapeutics, Inc. from 2014 to 2022; Independent Director at Bio-Rad Laboratories, Inc. from 2011 to 2013; Independent Director at Seagen, Inc. from 2020 to 2023; Independent Director at Mast Therapeutics, Inc. from 2012 to 2013; Director at Anesiva, Inc.; Independent Director at Santarus, Inc. from 2011 to 2014; Independent Director at Amicus Therapeutics, Inc. from 2012 to 2020; Lead Independent Director at Humanigen, Inc. in 2015; Director at Predix Pharmaceuticals, Inc.; Independent Director at Portola Pharmaceuticals LLC from 2019 to 2020; Director at ARCA biopharma, Inc. in 2009 and 2011; Independent Director at Cascadian Therapeutics LLC from 2014 to 2018; Independent Director at Affymax, Inc. from 2011 to 2013; Director at Stanford Health Care-Stanford Hospital; Director at California Healthcare Institute; Director at California Institute for Regenerative Medicine from 2004 to 2006; Director at The Biotechnology Institute; VP-Product Development & Regulatory Affairs at Genentech, Inc. from 1992 to 1998; Executive VP & Head-Research & Development at Onyx Pharmaceuticals, Inc. from 2011 to 2012; Senior Vice President-Development at Innoviva, Inc. from 1998 to 2001; and Senior Vice President-Development at Theravance Biopharma Us LLC from 1998 to 2001.
Education includes undergraduate degree from Haverford College and doctorate from Yale School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 58 393 ( 0,01% ) | 4 M $ | 31/08/2026 | |
| 30/04/2026 | 5 484 ( 0% ) | 802 529 $ | 31/08/2026 | |
| 31/08/2026 | 2 389 ( 0% ) | 598 875 $ | 31/08/2026 | |
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Ted Love
| Sociétés | Poste | Début |
|---|---|---|
| ROYALTY PHARMA PLC | Directeur/Membre du Conseil | 30/07/2020 |
| STRUCTURE THERAPEUTICS INC. | Directeur/Membre du Conseil | 03/08/2023 |
| GILEAD SCIENCES, INC. | Directeur/Membre du Conseil | 01/02/2024 |
| JAZZ PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 01/12/2025 |
Life Science Cares Bay Area | Directeur/Membre du Conseil | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 01/01/2025 |
Avillion LLP
 Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Directeur/Membre du Conseil | 22/07/2013 |
Anciens postes connus de Ted Love
| Sociétés | Poste | Fin |
|---|---|---|
| SEAGEN INC. | Directeur/Membre du Conseil | 14/12/2023 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur Général | 05/10/2022 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Ted Love
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
Bio-Rad Laboratories, Inc.
 Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain management | Health Technology |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing and commercializing pharmaceutical products for the treatment of upper & lower gastrointestinal diseases and disorders | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Haverford College
 Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Health Care
 Stanford Health Care Hospital/Nursing ManagementHealth Services Operates as healthcare center | Health Services |
California Healthcare Institute
 California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
California Institute for Regenerative Medicine
 California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services | Government |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Avillion LLP
Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Health Technology |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Life Science Cares Bay Area | Commercial Services |
